title: Early detection of acute myocardial infarction by measurement of mass concentration of creatine kinase-MB.
abstract: The diagnostic sensitivity and performance of immunoenzymometric measurements of creatine kinase (CK)-MB mass concentrations in the early diagnosis of acute myocardial infarction (AMI) were examined and compared with the sensitivities and performances of CK and CK-MB activity, in the context of simultaneous measurements of CK, CK-MB activity, and CK-MB mass concentrations in serially drawn blood samples obtained immediately from 36 patients with AMI and 126 patients with chest pain on admission to the emergency room of the department of internal medicine. In the 36 patients with AMI, who were all admitted no later than 4 hours after the onset of chest pain, pathologic increase occurred significantly earlier in CK-MB mass than in both CK and CK-MB activity, with a median difference of 1 hour each. In patients coming to the emergency room (51 with AMI, 51 with angina pectoris and 24 with chest pain not related to coronary artery disease), CK-MB mass was the best diagnostic measurement for AMI of all markers tested (significantly higher efficiency, Youden index and likelihood ratio than both CK and CK-MB activity). Before initiating thrombolytic therapy, the sensitivity of CK-MB mass is significantly higher than CK-MB activity during the 0- to 6-hour period and significantly higher than CK activity during the 2- to 4-hour period after the onset of chest pain. Consequently, it is often possible to diagnose an AMI on the basis of increased CK-MB mass concentrations even at a time when CK and CK-MB activities are still within the reference interval.
authors.affiliation: Department of Medical Chemistry and Biochemistry, University of Innsbruck School of Medicine, Austria.
authors.forename: J
authors.initials: J
authors.lastname: Mair
authors.forename: E
authors.initials: E
authors.lastname: Artner-Dworzak
authors.forename: A
authors.initials: A
authors.lastname: Dienstl
authors.forename: P
authors.initials: P
authors.lastname: Lechleitner
authors.forename: B
authors.initials: B
authors.lastname: Morass
authors.forename: J
authors.initials: J
authors.lastname: Smidt
authors.forename: I
authors.initials: I
authors.lastname: Wagner
authors.forename: C
authors.initials: C
authors.lastname: Wettach
authors.forename: B
authors.initials: B
authors.lastname: Puschendorf
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000787:Angina Pectoris / Q000175:diagnosis / Q000201:enzymology; D015415:Biomarkers / Q000097:blood; D002637:Chest Pain / Q000175:diagnosis / Q000201:enzymology; D003402:Creatine Kinase / Q000097:blood*; D004562:Electrocardiography; D004630:Emergencies; D005260:Female; D006801:Humans; D007527:Isoenzymes; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis* / Q000188:drug therapy / Q000201:enzymology; D011237:Predictive Value of Tests; D012680:Sensitivity and Specificity; D015912:Thrombolytic Therapy; D013997:Time Factors
chemical_list: D015415:Biomarkers; D007527:Isoenzymes; D003402:Creatine Kinase